• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,126.55 26.08
( 0.03%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
148.85
446792.16
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.86
 

Hindustan Unilever board OKs Rs 2,000-cr capex for capacity expansion
Feb 19,2026
The proposed investment is in line with the company’s strategy of focusing on fewer, bigger bets and strengthening its presence in high-growth demand spaces, including premium skin care and hair care and personal care & home care liquids.

Priya Nair, CEO and managing director, HUL, said: 'This investment reflects our strategic focus on scaling our brands and creating categories of the future to meet evolving consumer needs. It also underscores our commitment to building a resilient, technology-enabled supply chain that delivers superior value to consumers.'

Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.

The company's consolidated net profit zoomed 120.91% to Rs 6,603 crore on 5.74% jump in revenue from operations to Rs 16,235 crore in Q3 FY26 over Q3 FY25.

The counter fell 1.90% to end at Rs 2279.50 on the BSE.